Biography:
Dr. Levast studied Chemistry at the Grenoble1 University, France and graduated as MS in 2006. He received his PhD degree in 2010 at the François Rabelais University of Tours within the INRAE institute. After five years of postdoctoral fellowship at VIDO, University of Saskatchewan, to study PRRSV vaccination in swine; and at McGill to study immunity against S. aureus, he joined MaaT Pharma in 2016 to develop gut-derived microbiotherapeutics in infectious and oncological diseases. He joined BIOASTER in 2022 as project lead in the vaccines program.
Title : System serology approach on COVID-19 patients’ sera reveal specific immune pattern in the heterogeneous population: The COVIDAuRA study